Commitments and Contingencies (Details Narrative) - USD ($)	Dec. 31, 2018	Dec. 31, 2017
Amount of milestone payment payable	$ 7,500,000
Issuance of common stock value	33,637	$ 28,037
Aldoxorubicin [Member]
Issuance of common stock value	$ 18,300,000

The fair value, as of the date of each statement of financial position presented, of other assets which are owned but transferred to serve as collateral for the payment of the related debt obligation, and that are reclassified and separately reported in the statement of financial position because the transferee has the right by contract or custom to sell or re-pledge them.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 860
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728

Name:	us-gaap_PledgedAssetsSeparatelyReportedOtherAssetsPledgedAsCollateralAtFairValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant